Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Furuhashi M; Tuncman G; Görgün CZ; Makowski L; Atsumi G; Vaillancourt E; Kono K; Babaev VR; Fazio S; Linton MF; Sulsky R; Robl JA; Parker RA; Hotamisligil GS; Nature, 2007, vol. 447, issue 7147, p 959, ISSN 14764687. ISBN 14764687.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef